Dexcom, Inc. · NASDAQ:DXCM
Dexcom — Q3 2022 Earnings Presentation
12 slides from Dexcom's earnings presentation, Oct 27, 2022
Slide 1: Dexcom earnings Q3 2022
bexcom Dexcom earnings Q3 2022
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation contains “forward” looking statements that are based on our management's beliefs and assumptions and on information currently available to management. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-looking
Slide 3: Third quarter 2022
Third quarter 2022 idl © Strong growth with Key Financial Strategic $770 million in revenue Highlights Highlights 20% organic revenue growth! Delivered reacceleration in revenue | Initiated international roll-out of G7 (17% US; 28% OUS2) growth in US with launches in five countries Drove over 600 ba
Slide 4: Third quarter performance
Third quarter performance Total Revenue & Organic Growth Rate! ($MM) $800 $650 $698 $629 $600 $400 $200 +27% +20% +23% $0 Q3'21 Q4'21 Q122 Non-GAAP Operating Margin* 25% 20% | 19.0% 18% 10% 8.0% 2. Q3'21 Q421 QrT22 1. Excludes non-CGM revenue acquired in the trailing twelve months, as well as the im
Slide 5: 2022 Guidance as of October 27, 2022
2022 Guidance as of October 27, 2022 2022 Annual Revenue and Profitability Guidance Non-GAAP. Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin* . USD ES 2.86-2.91 ~65% ~16% ~25% billion Updated USD pdcte 2.88-2.91 ~64% ~16% ~25% billion *See appendix for reconciliations
Slide 6: Appendix: Revenue Data and GAAP Reconciliations
bexcom Appendix Revenue Data and GAAP Reconciliations
Slide 7: DexCom, Inc. GAAP to non-GAAP reconciliation
DexCom, Inc. dn millions) GAAP operating income Amortization of intangible assets Business transition and related costs ® Intellectual property litigation costs ©) Non-GAAP operating income GAAP net income Business transition and related costs Depreciation and amortization Intellectual property liti
Slide 8: Summary of changes in itemized GAAP and Non-GAAP reconciliation
Below is a summary of the changes in our “Itemized Reconciliation Between GAAP and Non-GAAP Financial Measures” we originally reported for the three months ended September 30, 2021 under the ASC 470-20 legacy guidance compared to the new simplified convertible instruments accounting guidance (ASU 20
Slide 9: Revenue Metrics By Component
Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 YTD'20 YTD'21 YTD'22 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 325.0 $ 364.5 $ 406.3 $ 465.6 $ 424.3 $ 494.5 $ 547.9 $ 598.6 $ 543.2 $ 597.7 $ 666.6 $1,095.8 $1,466.7 $1,807.5 Year over year growth 53% 4
Slide 10: Revenue Metrics By Geography
Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 YTD'20 YTD'21 YTD'22 Revenue Metrics By Geography US Revenue (millions) $ 292.3 $ 367.1 $ 398.6 $ 451.5 $ 381.2 $ 461.5 $ 489.6 $ 517.1 $ 451.2 $ 511.0 $ 573.4 $1,058.0 $1,332.3 $1,535.6 Year over year growth 39% 38% 29% 20% 30% 26% 2
Slide 11: Organic Revenue
Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 YTD'20 YTD'21 YTD'22 1 Organic Revenue OUS Revenue - Reported $ 112.8 $ 84.7 $ 102.3 $ 117.4 $ 123.8 $ 133.6 $ 160.6 $ 181.1 $ 177.6 $ 185.2 $ 196.2 $ 299.8 $ 418.0 $ 559.0 Impact of Acquired Revenue and Foreign Exchange 1.1 1.1 (2.4)
Slide 12: Definitions
Definitions: Amortization of intangible assets – We are required by GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non-cash amortization charges from our non-GAAP financial measures. Business tran